# Interest of Immersive Virtual Reality on Stress During Botulinum Toxin Injections in Spasticity (RVTOX)

> **NCT05364203** · NA · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 42 (actual)

## Conditions studied

- Central Neurogical Impairment

## Interventions

- **DEVICE:** DEEPSEN virtual reality mask

## Key facts

- **NCT ID:** NCT05364203
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-10
- **Primary completion:** 2024-12-02
- **Final completion:** 2024-12-02
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05364203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05364203, "Interest of Immersive Virtual Reality on Stress During Botulinum Toxin Injections in Spasticity (RVTOX)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05364203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*